Medical resuscitation is vital for protecting life and the practices and standards are always improving and evolving, according to Neonatal Research Leader and Mother and Baby Program Clinical Lead...
New research from the Queensland Family Cohort study shows what dads eat - even during their partner's pregnancy - will have a lasting effect on their unborn babies.
Important new transformative projects between Mater Researchers and Mater Health clinicians have been given the green light.
Mater is proud to welcome neurologist, epileptologist and medical researcher Professor Aileen McGonigal as our new Director of Epilepsy Unit and a Mater Research Group Leader.
When young people with Down Syndrome develop the rare but debilitating condition Catatonia and Acute Regression it is devastating for them and their families - but what causes it? Mater Researchers...
This International Women’s Day we asked Cancer Program co-leader Professor Kristen Radford to outline the lessons she learnt about leadership and success during her recent Fulbright Scholarship in...
Mater Research has released its 2021 Annual Report highlighting its outstanding achievements for the past year.
Ovarian cancer patients who undergo chemotherapy or surgical treatments often experience early menopause, with all the associated negative side effects, but research shows regular, sweat-inducing...
The Mater Research Publication Recognition Scheme winners have been announced.
Mater Research will begin trialling a new targeted immunotherapy in 2022 to treat a rare but devastating blood cancer thanks to a $2.8 million Medical Research Future Fund grant.
New PhD graduate Lena Batoon has a single focus – looking for a cure for bone cancer.
During the Christmas – New Year period, several Mater SEQ facilities and services will be closed or operating at reduced capacity.